Evidence map›Paper›PMID 42400646›Full record

ArticleNeuroradiology2026

Beyond complex architectures: a streamlined CNN pipeline for robust Alzheimer's disease classification from brain MRI.

Mohamed Amine Jabli, Moussa Mourad

Abstract read
PubMed Publisher
In one paragraph

Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohamed Amine JabliENISO, NOCCS, University of Sousse, Sousse, Tunisia. jeblimedamine@gmail.com.ORCID http://orcid.org/0000-0001-8605-0129
Moussa MouradENISO, NOCCS, University of Sousse, Sousse, Tunisia. mourad.enim@yahoo.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeAlzheimer's disease, a common type of dementia, gradually steals memories and impacts daily life as brain cells deteriorate. We explored how Artificial Intelligence (AI) could help spot early signs of Alzheimer's using MRI brain scans. MATERIALS AND

methodsOur study focused on a deep learning approach, specifically a convolutional neural network (CNN), to distinguish between Alzheimer's, Mild Cognitive Impairment (MCI), and healthy individuals. We used two well-known datasets, OASIS and ADNI, for this work. After carefully preparing the ADNI data (which included 21,324 MRI images: 7,572 from MCI patients, 5,904 from healthy controls, and 7,848 from Alzheimer's patients) and the OASIS data (6,400 MRI images), our model performed exceptionally well.

resultsThe CNN Model achieved an accuracy of 99.67% with the ADNI images and 99.06% with the OASIS images. These encouraging results, which stand up well against other studies, show that our method can effectively analyze large amounts of data and accurately classify Alzheimer's.

conclusionsOur main hope is that this kind of technology can give doctors and caregivers better tools to predict and detect the disease, ultimately saving time, reducing costs, and helping those affected by Alzheimer's.

Indexed as

Alzheimer DiseaseDeep LearningImage Interpretation, Computer-AssistedMagnetic Resonance ImagingCognitive DysfunctionConvolutional Neural NetworksFemaleHumansADNI (Alzheimer's Disease Neuroimaging Initiative)Alzheimer’sDeep learningTransfer learning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.